Latest autoimmune disease Stories
According to new report from BCC Research, the global market for autoimmune disease diagnostics is expected to grow to nearly $13.1 billion by 2019, with a five-year compound annual growth rate
-Enhances Capabilities for the Precision Medicine in Immuno-oncology and Autoimmune Disease Areas- LOS ANGELES and LEIPZIG, Germany, Sept. 17, 2014 /PRNewswire/ -- ImaginAb, Inc.
SHM-XEL Platform Successfully Generates Novel Therapeutic Approach to Autoimmune Disease SAN DIEGO, Sept.
Psoriasis is the most common autoimmune disease in the U.S.
ORLANDO, Fla, Aug. 27, 2014 /PRNewswire/ -- TNI BioTech Inc.
When faced with pathogens, the immune system summons a swarm of cells made up of soldiers and peacekeepers.
Supports progression of this first-in-class anti-TLR4 monoclonal antibody into clinical proof of concept study as a potential personalized medicine for rheumatoid arthritis GENEVA, August
HERZLIYA, Israel, July 16, 2014 /PRNewswire/ -- XTL Biopharmaceuticals Ltd.
MUMBAI,India, July 3, 2014 /PRNewswire/ -- - GBR 830 is an antagonistic monoclonal antibody with first in class potential for the treatment of
ORLANDO, Fla., June 24, 2014 /PRNewswire/ -- TNI BioTech, Inc.
- A volcanic mudflow.